Alice Mims, MD, MSCR is a hematologist/medical oncologist who specializes in treating patients suffering from acute leukemias and myeloid malignancies, particularly acute myeloid leukemia. She currently serves as an associate professor in the Division of Hematology and is the Acute Leukemia/Myeloid Malignancies Section Head at The Ohio State University. She also serves as a senior medical director on the national, multi-center study investigating novel treatment in older patients with acute myeloid leukemia through the Leukemia & Lymphoma Society’s Beat AML Master Trial. Her research training and efforts have been supported through the American Society of Hematology’s Clinical Research Training Institute and her accolades include an ASH Clinical Scholar Award, ASCO Conquer Cancer Foundation Young Investigator Award, and current R01 funding investigating new treatment options for patients with acute myeloid leukemia.
Dr. Mims has several publications related to these research projects and clinical trials in journals such as the New England Journal of Medicine, Nature Medicine, Cancer Discovery, and Lancet Haematology. Her goal is to continue collaborative efforts to improve treatment option and outcomes in patients with acute myeloid leukemia through the development of novel therapeutics through translational research and clinical trials.
Dr. Mims completed her medical degree at the Medical University of South Carolina and completed her residency in internal medicine at Wake Forest University Baptist Medical Center. She completed her medical oncology/T32 research fellowship at The Ohio State University Comprehensive Cancer Center – the James.